EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database

"EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database" published on 28 Mar 2025 by National Comprehensive Cancer Network.

Authors

Institutions

Publication Details

Journal
Journal of the National Comprehensive Cancer Network
Published
2025-03-28
DOI
https://doi.org/10.6004/jnccn.2024.7274
Citations
2
Primary Topic
Quinazolinone synthesis and applications
Type
article
Field-Weighted Citation Impact
1.87
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database

Shafaq Jawed, Syed Maaz Tariq
2 citations
Journal of the National Comprehensive Cancer Network
Quinazolinone synthesis and applications
1.87
article

EPR25-131: Hematologic Adverse Effects Profile of Immune Checkpoint Inhibitors: A Real-World Pharmacovigilance Study Using FAERS Database

Shafaq Jawed, Syed Maaz Tariq
article en
2 citations

Abstract

No abstract available for this paper.

Journal of the National Comprehensive Cancer NetworkVol. 23(3.5)
Riverview Medical Center (US), Lone Star College Kingwood (US)
Zero hunger
Openalex Percentile: Top 17%
Quinazolinone synthesis and applications
1.87
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.